ClinicalTrials.Veeva

Menu

Recurrence and Prognosis Prediction Model for Gastric Cancer

Fudan University logo

Fudan University

Status

Completed

Conditions

Gastric Cancer (GC)

Treatments

Other: surgery and/or chemo

Study type

Observational

Funder types

Other

Identifiers

NCT07243847
Prediction model(GC)

Details and patient eligibility

About

This study, utilizing a large-scale multicenter Eastern database, has established a Deep Learning-based predictive model for recurrence following gastric cancer surgery, which demonstrates robust discriminatory power for early recurrence. Furthermore, the individualized recurrence probability generated by this model can predict long-term postoperative prognosis and effectively stratify patients based on risk, thereby guiding personalized treatment choices. This individualized risk probability is also applicable to both adjuvant chemotherapy and neoadjuvant chemotherapy populations, offering valuable support for precision treatment in gastric cancer.

Enrollment

5,000 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

Pathologically confirmed gastric adenocarcinoma; No distant metastases confirmed by preoperative examinations such as chest X-ray, abdominal ultrasonography, and upper abdominal computed tomography; Achievement of R0 resection.

Exclusion criteria

Presence of distant metastases detected preoperatively or intraoperatively; Prior neoadjuvant chemotherapy or radiotherapy; Incomplete general clinical data.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems